The European Union is moving toward approval of Ukraine’s reform plan in May, which would unlock an additional €1.9 billion ($2 billion) as part of a total €15.9 billion that the bloc has planned in financial aid for Kyiv for this year.
The European Commission has granted marketing authorization to the combination of zanubrutinib and obinutuzumab for the treatment of adult patients with relapsed/refractory follicular lymphoma following at least 2 prior lines of systemic therapy.
Novavax's Covid-19 vaccine is likely to receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the World Health Organization, a report said on Thursday.